Dynex Capital Operating Cash Flow increased by 388.3% to $69.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 997.7%, from $6.36M to $69.85M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -4.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.67M | $40.87M | $38.24M | $34.55M | $36.19M | $25.54M | $30.07M | $3.74M | $31.49M | $10.40M | $16.57M | -$17.10M | $18.61M | -$2.26M | $15.14M | $6.36M | $31.88M | $68.28M | $14.30M | $69.85M |
| QoQ Change | — | +8.5% | -6.4% | -9.7% | +4.7% | -29.4% | +17.8% | -87.6% | +742.7% | -67.0% | +59.3% | -203.2% | +208.8% | -112.1% | +771.5% | -58.0% | +401.0% | +114.2% | -79.0% | +388.3% |
| YoY Change | — | — | — | — | -3.9% | -37.5% | -21.4% | -89.2% | -13.0% | -59.3% | -44.9% | -557.7% | -40.9% | -121.7% | -8.6% | +137.2% | +71.3% | >999% | -5.5% | +997.7% |